Clinical pharmacology unit
Related services
Phase I/IIa clinical trials are pivotal in selecting your successful leads. Xendo’s sophisticated clinical pharmacology unit is fully equipped to safely conduct your clinical research. Our CPU fully benefits from its location at the premises of the University Medical Centre in Groningen.
Contact clinical pharmacology unit
Jelle Hempenius, senior director business development
- Telephone: +31 (0)50 304 80 04
- Email: jelle.hempenius@xendo.com
Scope of services clinical pharmacology unit
- Types of clinical studies conducted at Xendo
- First administration into man
- Bioavailability / bioequivalence
- Drug-drug and drug-food interaction
- Proof of principle (POP) and proof of concept
- Drug metabolism
- Safety and tolerability (phase I)
- Dose ranging
- Micro dosing
- Early patient (phase IIa)
- Special population, e.g. elderly, postmenopausal women
- Routes of administration
- Intravenous (IV), intramuscular (IM) and subcutaneous (SC) injections
- Inhalants, intranasal, ophthalmic
- Oral, buccal, sublingual, rectal
- Transdermal, topical
